|
Market Closed -
Other stock markets
|
Pre-market 04:00:00 | |||
| 355.25 USD | -1.44% |
|
345.94 | -2.62% |
| 07-13 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
| 07-13 | UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 195B | |||||
| 1,054B | |||||
| 621B | |||||
| 438B | |||||
| 325B | |||||
| 281B |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
